Frist Cressey Ventures Launches $425M Fund to Fuel AI-Driven Healthcare Innovation
Frist Cressey Ventures (FCV) has announced the successful closing of its oversubscribed fourth fund, totaling $425 million. This modern fund brings the firm’s total assets under management to nearly $1 billion and will focus on investing in early-stage healthcare companies leveraging artificial intelligence (AI) to reshape care delivery.
Strategic Partnerships Drive Investment
FCV is partnering with several key health systems, including MedStar Health and OhioHealth, as strategic investors and collaborators. These partnerships, along with The Cigna Group, provide access to healthcare services reaching over 50% of the U.S. Population. This extensive network offers portfolio companies potential pilot programs, contracts, and scaled distribution opportunities.
Focus on AI and Transforming Care
Fund IV will prioritize “AI-native” business models – companies built from the ground up with AI embedded in their core operations, rather than retrofitting existing systems. While continuing to support value-based care models, FCV will aggressively expand into AI-enabled service models designed to improve efficiency, clinical decision-making, and patient engagement. The firm aims to invest in companies that are transforming care delivery with technology and tech-enabled services.
Proven Track Record and Investor Confidence
The oversubscribed fund reflects strong confidence in FCV’s investment strategy and track record. Funds I and II rank in the top 5% of all venture capital funds for their respective vintages. To date, FCV has made 44 total investments and achieved 14 successful exits.
“This milestone reflects the clarity of purpose, conviction, and deep commitment of our team, investors, and portfolio companies, all united by a shared mission to advance innovation in healthcare that improves lives and keeps patients at the center of everything we do,” said Sen. Bill Frist, MD, Co-Founder and Managing Partner, Frist Cressey Ventures.
Jesse Longoria, senior vice president and chief strategy and growth officer of OhioHealth, stated, “We are growing our partnership and engagement with Frist Cressey due to the fact that of its proven combination of meaningful strategic value while generating top decile investment returns. The collaboration with Frist Cressey will facilitate us see around corners and bring innovative opportunities to our organization.”
Bill Sheahan, senior vice president and chief innovation officer of MedStar Health and executive director of the MedStar Institute for Innovation, added, “We have a greater opportunity than ever to use tech to address some of the most complex challenges in healthcare. Frist Cressey helps us identify real innovations, and advises on where we should be spending our time and capital.”
Looking Ahead
With a growing portfolio and a renewed focus on AI-driven healthcare solutions, Frist Cressey Ventures is poised to play a significant role in shaping the future of care delivery. The firm’s unique combination of venture capital expertise and strategic healthcare partnerships positions it to identify and support the next generation of healthcare innovators.